This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesDisease AwarenessDisease AwarenessAspergillosisOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseINSPIRE To: Change the Course Season 2The global threat of carbapenemase-producing enterobacterales (CPE)CPE Epidemiology CPE Factsheet London AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

Online Learning
INSPIRE To: Change the Course

Welcome to INSPIRE To: Change the Course Season 2 online learning. This is a 4 module course which discusses managing fungal infections in the ICU, radiological & laboratory diagnostic approaches for Invasive Fungal Infections, the role of radiology in fungal MDT, and complex patient case studies. 

Together with a group of leading experts in antimicrobial stewardship, we have developed a series of presentations and workshops designed to provide you with the knowledge and confidence to manage invasive fungal infections and implement diagnostic approaches. After completing 2 modules, you will be able to download a certificate of completion with 1 CPD accreditation from the The Royal College of Pathologists. Completing this entire course is worth 2 CPD credits.

Start browsing the courses below to begin your online learning, and your journey to Change the Course.

Dr. Neil Stone & Lisa Nwankwo 

Old moulds, new problems – Fungal infections in the ICU
 

From this course you will learn:

  • The risk factors and signs of fungal infections in the ICU
  • The importance of judicious use of antifungal therapies
  • What antifungal therapies are currently available, and their potential applications, strengths and limitations
  • Pharmaceutical management of IA in the ICU, and key considerations when selecting treatments
  • Practical management of IA in a real-life patient case
Total time complete: 20 minutes
Start LearningLoading
Dr. Hasti Robbie & Claire Berry 

Radiological & Laboratory Diagnostic approaches for Invasive Fungal Infections (IFIs)

From this course you will learn:

  • The subtypes of IPA and their characteristic pathophysiological features
  • Which patients are most at risk of developing IPA
  • The importance of radiology in diagnosing IPA, and the typical CT signs of IPA
  • Practical management of IPA in a real-life patient case
Total time to complete: 15 minutes
Start Learning
Loading
Drs. Meg Coleman & Sarah Sheard

Foraging for Mushrooms: The role of Radiology in the Fungal MDT

Coming soon!

Dr. Varun Mehra, Dr. Chris Kosmidis & Hafia Lyster 

Managing Fungal Infections in Complex Patients: a case study series

Coming soon!

    Start your learning now

    Begin the first video in the series: "Candidaemia in the ICU"

    (02:34 min)

    Go to videoLoading
    Access more antimicrobial stewardship resources

    Get further information on antimicrobial stewardship including a variety of resources for antibacterial and antifungal stewardship on the Anti-infectives section of PfizerPro 

    Visit Anti-infectivesLoading


    MDT, Multidisciplinary team; ICU, Intensive care unit; IPA, Invasive pulmonary aspergillosis; ECMO, Extracorporeal membrane oxygenation; IA, Invasive aspergillosis; CT, Computed tomography 

    CRESEMBA®  is indicated in adults for the treatment of: 1. invasive aspergillosis 2. mucormycosis in patients for whom amphotericin B is inappropriate. Consideration should be given to official guidance on the appropriate use of antifungal agents. 

    Prescribing Information:

    Click here for CRESEMBA® (isavuconazole)

    PP-CRB-GBR-2499. June 2024

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

    for MHRA Yellow Card in Google Play or Apple App Store

     

    Adverse events should also be reported to Pfizer Medical Information on 01304 616161

    PfizerPro Account

    To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

    Sign In or RegisterAccountSign Out

    This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

     

    This website is brought to you by Pfizer Limited, a company registered in England 

    and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

     

    Copyright © 2024 Pfizer Limited. All rights reserved.

     

    VAT registration number GB201048427

    PP-UNP-GBR-7866. January 2024
    For UK Healthcare Professionals*

    These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

    I confirm that I am a healthcare professional* resident in the United Kingdom.

    If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

    *The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

    PP-UNP-GBR-7812. January 2024

    YesNo
    You are now leaving PfizerPro​​​​​

    ​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

    Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

    ​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
    ​​​​​​​
    You are now leaving PfizerPro
    ​​​​​​​
    ​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

    Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
    business which it has provided or reviewed.

    PP-PFE-GBR-3859. November 2021
    ​​​​​​​